The Joint Blog

JANUARY 23, 2020

.” For this study, “The first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric disorders was conducted.” One isolated study indicates some potential efficacy for an oral cannabinoid /terpene combination in ADHD.

Clinical Trials 52

Clinical Trials Sleep Marijuana Cannabinoids 52

CannaMD

SEPTEMBER 28, 2020

These represent the two most often studied cannabinoids overall, and sleep research is no different. Both cannabinoids have been studied separately for their abilities. For example, high-CBD strains are also high in myrcene , a sedating terpene compound. Research is complex because there are compounding factors.

Sleep 72

Sleep Clinical Trials Patients THC 72

Greencamp

AUGUST 16, 2018

The available body of evidence suggests that besides the lessening of symptoms, cannabis is also capable of slowing down the overall rate of progression of this horrible condition. Modern science hasn’t found a cure for this condition so far, and the most frequent cause of death is respiratory failure due to muscle decay.

Strains 94

Strains Cannabinoids Research and Development Indica 94

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 98

CBD Blood Pressure Clinical Trials Tincture 98

The Cannigma

JUNE 15, 2021

Cannabidiol (CBD) belongs to a class of molecules called cannabinoids , which are produced almost exclusively in cannabis — hence the name. The two cannabinoids can also cause very different effects in other ways. CBD is also often compared to CBG (cannabigerol) , another increasingly popular cannabinoid. CBD vs CBDA.

CBD 122

CBD Research and Development Epilepsy Extraction 122

Canna Care Docs

JUNE 22, 2018

While cannabis has been used for medical, religious, and recreational purposes for over 5,000 years (1) , THC, as an isolated cannabinoid derived from the plant was first discovered by Raphael Mechoulam and Yechiel Goani in 1964 (2). Cannabinoid pharmacology: the first 66 years. Works Cited. Pertwee RG. British Journal of Pharmacology.

THC 66

THC Patients Blood Pressure Clinical Trials 66

The Cannigma

JULY 1, 2022

Because of this variability in the plant, and because of a lack of standard methods–like chemical analyses of cannabinoids or terpenes–has led to inconsistent scientific results. This is because these types of studies control the most variables to ensure that the results that come out of the trial are as reliable as possible.

Research and Development 108

Research and Development Data THC Clinical Trials 108

TheAnswerPage

JANUARY 11, 2022

and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ In addition, if clinicians are not well informed about the health effects of cannabinoid-based products, clinicians will not be able to optimally treat their patients. million medical marijuana patients nationwide.

Patients 98

Patients Education Marijuana Therapy 98

CannaTech

SEPTEMBER 16, 2018

These guidelines outline a list of qualifying conditions that patients must possess in order to legally obtain medical cannabis. Over time extended clinical trials will continue to map out the plant’s therapeutic effects, supporting it as an alternative medicine offering relief for a long list of conditions.

Education 66

Education Medicine Clinical Trials Patients 66

CannaMD

AUGUST 8, 2020

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system.

CBD 99

CBD DEA Research and Development Hemp 99

Miss Marijuana

MAY 13, 2020

What most people don’t understand is that CBD may be helpful for symptom management for conditions such as anxiety, inflammation, pain, sleep and certain types of seizures, however, figuring out how to achieve those effects is a bit more complicated. Topicals – These are a common way to use CBD for skin conditions or joint/pain issues.

CBD 52

CBD Blood Pressure Clinical Trials Tincture 52

Sensi Seeds

NOVEMBER 23, 2018

However, recent research on the cannabinoid and terpene profiles of different cannabis varieties mean we need to reassess what we thought we know about indicas and sativas being defined by their THC:CBD ratio. And yet others swear by hybrids, for the best of both worlds. What type of cannabis will make you laugh?

Blood Pressure 81

Blood Pressure Indica Clinical Trials Sativa 81

Project CBD

OCTOBER 26, 2023

There is a growing body of anecdotal and scientific evidence that the “major cannabinoids” tetrahydrocannabinol (THC) and cannabidiol (CBD), certain “minor cannabinoids” (some without a name), and other cannabis compounds have antineoplastic action against cancer cells. THC binds to two types of cannabinoid receptors, CB1 and CB2.

Research and Development 343

Research and Development Cannabinoids Terpenes Pharmaceutical 343

Project CBD

MAY 3, 2023

Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids. Is that because CBG is a precursor for the other plant cannabinoids?

Cannabinoids 209

Cannabinoids Sleep Clinical Trials CBD 209

Veriheal

SEPTEMBER 6, 2022

Recent research has found that terpene and cannabinoid profiles are far more significant when trying to produce specific effects. Recent research has found that certain cannabinoids may help with sleep. Terpene and cannabinoid profiles of the cannabis you are consuming will also impact the effects experienced.

Sleep 105

Sleep THC CBD Chronic Pain 105

The Cannigma

APRIL 8, 2021

The doctor diagnoses the condition and chooses a specific medicine. Yeah, there are thousands of strains, but those thousands of strains, but those thousands of strains only make let’s say one or two of 60 cannabinoids in abundance. Half of those cannabinoids of plant doesn’t make or three quarters because they’re byproducts.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Alchimia

JANUARY 25, 2022

Assuming clinical trials go well, the ultimate hope of the researchers is to develop a pill containing purified versions of these acidic cannabinoids as an adjunct to vaccination, for use after known exposure or by those who are immunocompromised. Why does CBD work best when combined with other cannabinoids and terpenes?

Research and Development 98

Research and Development Terpenes CBD Treatment 98

Cannabis Law Report

AUGUST 12, 2019

Today, modern science has identified a family of molecules known as cannabinoids as well as the human endocannabinoid system. Broad spectrum CBD oil contains a variety of active compounds such as cannabinoids and terpenes, which we will discuss in greater detail in Section 2. Purified cannabinoids are colorless and odorless.

CBD 40

CBD Terpenes Oil Tincture 40

The Cannigma

FEBRUARY 11, 2021

Listen & Subscribe: When Mara Gordon started using medical cannabis there wasn’t any lab testing — or any way to know how much of each cannabinoid or terpene was in a given strain. One of the things she does is collect and analyze data about cannabis products and how patients with different medical conditions respond to them.

Wellness and Beauty 125

Wellness and Beauty Data Patients Medicine 125

Green Relief

MAY 13, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

THC 64

THC CBD Cannabinoids Research and Development 64

Green Relief

MAY 12, 2018

government-held patent pertaining to “cannabinoids as antioxidants and neuroprotectants,” CBD and THC can limit “neurological damage following ischemic insults, such as stroke or trauma.”. As yet there have been no FDA -approved clinical trials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury.

Research and Development 40

Research and Development Cannabinoids Therapy CBD 40

The Cannigma

MARCH 12, 2021

However, many customers, new medical cannabis customers are going into the dispensary with a note from their doctor saying you qualify under one of the state conditions that enable you to use cannabis. They want also maybe CBD and they want terpenes and they want other cannabinoids in there. But what do we do in the meantime?

Legalization 128

Legalization Patients Education Dispensary 128

Cannabis Law Report

NOVEMBER 24, 2021

Medicinal cannabis has been legalised for use for a range of specified medical conditions in Australia since 2016. We also used manifest textual analysis to search for word frequencies, and specific conditions referred to in the articles retrieved. Medical publications, are, in the main fairly positive toward cannabis. Background.

Research and Development 52

Research and Development Medicine Access Media 52

Project CBD

NOVEMBER 11, 2023

And then cannabis has unique effects for a wide range of conditions, everything from the treatment of pain, treatment of asthma, treatment of immune conditions. There’s a condition that we call GERD, gastroesophageal reflux disease. there’s been a great deal of promotion of CBD for a wide variety of conditions.

Medicine 301

Medicine Research and Development Pharmaceutical Cannabis 301

Cannabis Law Report

NOVEMBER 7, 2019

With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient. Cannatrek is actively working on clinical trial protocols with a dedicated focus on mental health.

Medicine 40

Medicine Patients Research and Development Clinical Trials 40

The Cannigma

JULY 20, 2021

And physical conditions such as diabetes, kidney diseases, neurological disorders and hormonal imbalance. This guide will focus on finding weed strains that may help with depression, anxiety and stress – the main psychological and emotional conditions that can cause issues with desire, arousal and orgasm. Best terpenes for sex.

Strains 145

Strains Terpenes Concentrates THC 145

Cannabis Law Report

OCTOBER 29, 2019

Wakshlag is well-known in the veterinary medicine community as the first doctor to conduct an efficacy study in dogs in a clinical trial at Cornell using ElleVet CBD/CBDA on dogs with multi-joint discomfort. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement.

Safety 45

Safety CBD Clinical Trials Oil 45

Cannabis Law Report

JULY 12, 2019

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

Extraction 73

Extraction Pharmaceutical CBD Epilepsy 73

Freedom Leaf

JANUARY 10, 2018

“We’re actively working toward developing new genetics to work on efficacy and assist the patients in Israel still operating with our nurse-run clinics in order to better provide the right dosage and strains for the patients who are referred to us by the Ministry of Health,” Stephen Gardner, Tikun Olam’s chief marketing officer, tells Freedom Leaf.

Research and Development 49

Research and Development Clinical Trials Strains Patients 49

Cannabis Law Report

JUNE 4, 2021

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Dr Rosalind Watts is a clinical psychologist, and the clinical lead of the Psilocybin for Depression trial at Imperial College London.

Research and Development 51

Research and Development Medicine Treatment Pharmaceutical 51